Stay updated on RTX-240 Combo with Pembrolizumab in Clinical Trial
Sign up to get notified when there's something new on the RTX-240 Combo with Pembrolizumab in Clinical Trial page.

Latest updates to the RTX-240 Combo with Pembrolizumab in Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page’s footer revision label has been updated from **v3.5.0** to **v3.5.3**, reflecting a site/version change rather than any modification to the underlying study record.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check44 days agoChange DetectedAdded Revision: v3.5.0 to the history. Removed Revision: v3.4.3 from the history.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision: v3.4.3 was added and v3.4.2 was removed from the history.SummaryDifference0.1%

- Check80 days agoChange DetectedA new revision entry (v3.4.2) was added and an older entry (v3.4.1) was removed, updating the record's version history.SummaryDifference0.1%

- Check88 days agoChange DetectedThe revision label on the page was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check88 days agoChange DetectedThe history shows a new revision tag v3.4.1 replacing v3.4.0, with no substantive changes to study data or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to RTX-240 Combo with Pembrolizumab in Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RTX-240 Combo with Pembrolizumab in Clinical Trial page.